Toronto, Canada

Hubert H Van Tol

This inventor holds 4 USPTO granted patents. Top assignee: State of Oregon. Active years: 1995-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1995-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Hubert H Van Tol

Introduction

Hubert H Van Tol is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pharmacology, particularly in the study of dopamine receptors. With a total of 4 patents to his name, Van Tol's work has had a profound impact on understanding psychotropic compounds and their applications.

Latest Patents

One of Van Tol's latest patents focuses on the human dopamine receptor and its uses. This invention is directed toward the isolation, characterization, and pharmacological use of the human D4 dopamine receptor. The patent provides the nucleotide sequence of the gene corresponding to this receptor and its allelic variants. Additionally, it includes recombinant eukaryotic expression constructs capable of expressing the human D4 dopamine receptor in cultures of transformed eukaryotic cells. This invention also offers methods for characterizing novel psychotropic compounds using such cultures.

Career Highlights

Throughout his career, Hubert H Van Tol has been associated with various research initiatives and has contributed to advancing the understanding of dopamine receptors. His work has been instrumental in developing new methodologies for studying psychotropic compounds, which are crucial for therapeutic applications.

Collaborations

Van Tol has collaborated with esteemed colleagues such as Olivier Civelli and David K Grandy. These partnerships have enriched his research and expanded the scope of his inventions.

Conclusion

Hubert H Van Tol's innovative work in the field of pharmacology, particularly regarding dopamine receptors, showcases his dedication to advancing scientific knowledge. His contributions continue to influence research and development in psychotropic compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…